mTERT (572-580)

mTERT

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-554

Synonyms/Alias:mTERT (572-580); hTERT R572Y peptide

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
YLFFYRKSV
Areas of Interest
Antigen-presenting Cells; Cancer Research

mTERT (572-580) is a synthetic peptide segment derived from the mouse telomerase reverse transcriptase (mTERT) protein, encompassing amino acids 572 to 580 of the full-length enzyme. As a functional fragment of the catalytic subunit of telomerase, this peptide is of significant interest in the study of telomere biology, cellular aging, and genome stability. Its sequence is strategically positioned within a region implicated in the regulation of telomerase enzymatic activity and protein-protein interactions, making it a valuable tool for dissecting the molecular mechanisms governing telomerase function. Researchers utilize this peptide to probe the structure-function relationships within mTERT, explore its post-translational modifications, and assess its role in telomerase complex assembly.

Peptide mapping: mTERT (572-580) serves as an essential reagent for peptide mapping studies aimed at elucidating the structural domains of telomerase reverse transcriptase. By incorporating this defined sequence into mapping protocols, scientists can precisely localize functional motifs, phosphorylation sites, or interaction domains within mTERT. Such mapping is critical for understanding how specific regions contribute to the overall activity and regulation of telomerase, and for identifying potential sites of modulation by cellular factors or small molecules.

Protein interaction studies: The peptide is highly useful in in vitro assays designed to investigate protein-protein interactions involving the telomerase complex. By employing mTERT (572-580) as a bait or competitor peptide, researchers can assess its capacity to mediate or disrupt binding with telomerase-associated proteins, such as telomerase RNA, shelterin components, or regulatory cofactors. These studies provide mechanistic insights into the assembly and regulation of the telomerase holoenzyme, informing broader research into telomere maintenance and genome integrity.

Antibody generation and epitope mapping: As a defined antigenic determinant, mTERT (572-580) is frequently utilized in the development and validation of sequence-specific antibodies. Its application in immunization protocols or affinity purification enables the generation of antibodies that selectively recognize the corresponding region of mTERT. Additionally, the peptide is instrumental in epitope mapping experiments, facilitating the characterization of antibody binding sites and supporting the development of high-specificity immunodetection tools for telomerase research.

Post-translational modification analysis: The sequence encompassed by mTERT (572-580) is a candidate for various post-translational modifications, including phosphorylation or acetylation, which may influence telomerase activity or protein stability. Synthetic access to this peptide allows for the systematic study of such modifications in vitro, either by direct chemical modification or enzymatic treatment. These analyses contribute to a deeper understanding of the regulatory mechanisms that control telomerase function in cellular contexts.

Functional assays: The defined structure of mTERT (572-580) enables its use in functional assays that interrogate the biological relevance of this region within the telomerase enzyme. Researchers may introduce the peptide into cellular or cell-free systems to assess its impact on telomerase activity, complex formation, or subcellular localization. Such experiments help delineate the contribution of specific mTERT segments to the enzyme's catalytic and regulatory properties, advancing the broader field of telomere biology and aging research.

Source#
Homo sapiens (human)
Epitope
572-580
Restricting HLA
HLA-A2
References
Irini Bolonaki; Journal of clinical oncology 2007

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicescGMP Peptide ServicePeptide Analysis ServicesPeptide CDMOPeptide Nucleic Acids SynthesisEpitope Mapping ServicesPeptide Modification ServicesCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers